Medtronic (MDT) Cash from Investing Activities (2014 - 2026)

Medtronic has reported Cash from Investing Activities for 13 years, with the latest figure at -$917.0 million in Q2 2026.

• Quarterly Cash from Investing Activities fell 87.14% year-over-year to -$917.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$2.9 billion (down 51.47% YoY) and the FY2026 annual result came in at -$2.9 billion, down 51.47% from the prior year.
• Cash from Investing Activities eased to -$917.0 million in Q2 2026 per MDT's latest filing, from -$816.0 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $271.0 million in Q2 2022 and troughed at -$1.6 billion in Q3 2022.
• A 5-year average of -$605.3 million and a median of -$514.5 million in 2023 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities jumped 84.24% in 2022, then slumped 275.28% in 2023.
• Over 5 years, Cash from Investing Activities stood at -$1.1 billion in 2022, then jumped by 63.0% to -$424.0 million in 2023, then gained by 18.63% to -$345.0 million in 2024, then tumbled by 39.71% to -$482.0 million in 2025, then plunged by 90.25% to -$917.0 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$917.0 million, -$816.0 million, and -$482.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.